BioPharma Resources

Drug Trial Radar · NCT04143451

Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients

Intradermal Quadrivalent Influenza Vaccine With Topical Imiquimod in Elderly & Chronic Ill Subjects, a Double-Blind Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Apr 28, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 4,000 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

4,000

Planned (sponsor's estimate)

Start

Oct 23, 2019

Primary completion

Sep 30, 2022

Study completion Mar 31, 2023

Sponsor

Lead sponsor
The University of Hong KongAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 29, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the safety and clinical efficacy (death, overall hospitalization, hospitalization for influenza or pneumonia) of ID QIV delivered via an intradermal device with imiquimod cream pretreatment with conventional intramuscular (IM) standard dose QIV and IM high-dose TIV

Conditions

  • Influenza

Interventions

  • Vaxigrip tetraBiological

    quadrivalent influenza vaccine

  • Fluzone high-doseBiological

    high-dose trivalent influenza vaccine

  • Aldara 5% Topical CreamDrug

    imiquimod cream

  • Aqueous cream BPDrug

    inactive aqueous cream

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MortalityTime frame: 3 years
  2. Overall hospitalisationTime frame: 3 years
  3. Hospitalisation for influenzaTime frame: 3 years
  4. Hospitalisation for pneumoniaTime frame: 3 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Hong Kong, Queen Mary Hospital

    Hong Kong, Hong Kong · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.